Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
HUMANIGEN, INC (HGEN)
|
Add to portfolio |
|
|
|
| Price: |
$3.73
| | Metrics |
| OS: |
119.1
|
M
| |
|
|
| Market cap: |
$444
|
M
| |
|
|
|
Net cash:
|
$3.1
|
M
| |
$0.03
|
per share
|
|
EV:
|
$441
|
M
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
($105)
|
M
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| Revenues | 3.6 | 0.3 | 0.0 | 0.0 | 0.0 | 19.6 | 0.0 | 0.0 |
| Revenue growth | 1052.2% | | | | -100.0% | | | -100.0% |
| Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Gross profit | 3.6 | 0.3 | 0.0 | 0.0 | 0.0 | 19.6 | 0.0 | 0.0 |
| Gross margin | 100.0% | 100.0% | | | | 100.0% | | |
| Research and development | 213.1 | 72.7 | 2.6 | 2.2 | 11.2 | 10.4 | 16.7 | 26.6 |
| General and administrative | 23.3 | 15.8 | 6.3 | 9.1 | 7.9 | 8.4 | 14.3 | 10.1 |
| EBIT | -232.8 | -88.2 | -8.9 | -11.3 | -19.0 | -18.0 | -34.4 | -36.7 |
| EBIT margin | -6474.9% | -28268.6% | | | | -91.8% | | |
| Pre-tax income | -215.0 | -89.5 | -10.3 | -12.0 | -22.0 | -27.0 | -35.4 | -38.0 |
| Income taxes | 21.6 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Tax rate | | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | -236.6 | -89.5 | -10.3 | -12.0 | -22.0 | -27.0 | -35.4 | -38.0 |
| Net margin | -6582.7% | -28697.1% | | | | -137.7% | | |
| |
| Diluted EPS | ($4.04) | ($2.42) | ($0.46) | ($0.13) | ($1.47) | ($2.78) | ($8.58) | ($9.22) |
| Shares outstanding (diluted) | 58.5 | 37.0 | 22.4 | 94.8 | 15.0 | 9.7 | 4.1 | 4.1 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|